ACRS vs POOL · rev $18.7M vs P/E 18, rev $5.31B
Aclaris Therapeutics Inc (ACRS) versus Pool Corporation (POOL) — a side-by-side from cached financials, not a winner call.
Aclaris Therapeutics Inc (ACRS) is a biotechnology company listed on NASDAQ.
Pool Corporation (POOL) is a industrial distribution company listed on NASDAQ.
Latest reported ACRS revenue for 2024-12-31 was $18.7M. Net income was -$132.1M. Revenue was down 40.1% from 2023-12-31 to 2024-12-31. ACRS currently screens at market cap $615.9M.
Latest reported POOL revenue for 2024-12-31 was $5.31B. Net income was $434.3M. Revenue was up 429.5% from 2023-12-31 to 2024-12-31. POOL currently screens at market cap $7.08B and trailing P/E 17.9.
ACRS currently screens at market cap $615.9M. POOL currently screens at market cap $7.08B and trailing P/E 17.9.
Not investment advice. Open the ACRS and POOL stock pages for the full models.
Not investment advice.